192 related articles for article (PubMed ID: 17343685)
1. Malignancies of the colorectum and anus in solid organ recipients.
Aigner F; Boeckle E; Albright J; Kilo J; Boesmueller C; Conrad F; Wiesmayr S; Antretter H; Margreiter R; Mark W; Bonatti H
Transpl Int; 2007 Jun; 20(6):497-504. PubMed ID: 17343685
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
3. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
4. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
6. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
8. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
10. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract][Full Text] [Related]
11. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients.
Stelzmueller I; Lass-Floerl C; Geltner C; Graziadei I; Schneeberger S; Antretter H; Mueller L; Zelger B; Singh N; Pruett TL; Margreiter R; Bonatti H
Transpl Int; 2008 Jun; 21(6):534-46. PubMed ID: 18363572
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study.
Tessari G; Naldi L; Boschiero L; Cordiano C; Piaserico S; Fortina AB; Cerimele D; La Parola IL; Capuano M; Gotti E; Ruggenenti P; Sassi F; Remuzzi G; Girolomoni G
Eur J Dermatol; 2006; 16(5):553-7. PubMed ID: 17101478
[TBL] [Abstract][Full Text] [Related]
13. Colorectal and anal neoplasms following liver transplantation.
Albright JB; Bonatti H; Stauffer J; Dickson RC; Nguyen J; Harnois D; Jeanpierre C; Hinder R; Steers J; Chua H; Aranda-Michel J
Colorectal Dis; 2010 Jul; 12(7):657-66. PubMed ID: 19508543
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies.
Fiebiger W; Kaserer K; Rodler S; Oberbauer R; Bauer C; Raderer M
Oncology; 2009; 77(5):314-7. PubMed ID: 19940522
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors.
Ollech JE; Kramer MR; Peled N; Ollech A; Amital A; Medalion B; Saute M; Shitrit D
Eur J Cardiothorac Surg; 2008 May; 33(5):844-8. PubMed ID: 18339554
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
Kellerman L; Neugut A; Burke B; Mancini D
Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
[TBL] [Abstract][Full Text] [Related]
17. Malignancy in pediatric transplant recipients.
Buell JF; Gross TG; Thomas MJ; Neff G; Muthiah C; Alloway R; Ryckman FC; Tiao GM; Woodle ES
Semin Pediatr Surg; 2006 Aug; 15(3):179-87. PubMed ID: 16818139
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.
Buadi FK; Heyman MR; Gocke CD; Rapoport AP; Hakimian R; Bartlett ST; Sarkodee-Adoo C
Am J Hematol; 2007 Mar; 82(3):208-14. PubMed ID: 17022049
[TBL] [Abstract][Full Text] [Related]
19. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
20. Malignancy after kidney transplantation: results of 400 patients from a single center.
Stratta P; Morellini V; Musetti C; Turello E; Palmieri D; Lazzarich E; Cena T; Magnani C
Clin Transplant; 2008; 22(4):424-7. PubMed ID: 18312442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
